NovoCure Ltd. 13F holders
218 funds reported a position in NovoCure Ltd. in their 13F for the quarter ended 30 June 2026, together 103.6 million shares worth $1.57 billion. Against the quarter before, 27 opened a position, 90 added, 63 trimmed and 35 sold out; together they bought a net 4.7 million shares. The largest holders: FMR LLC, BlackRock, Inc. and Soleus Capital Management, L.P.
Funds holding218-6 on Q1 2026
Shares they held103.6Mworth $1.57 billion
Net bought on the quarter4.7M sharesabout $71.6 million at the funds' values
Funds buying to selling117 to 98opened or added, to cut or sold
Opened 27Added 90Held 36Trimmed 63Sold out 35
What each fund did in NVCR against its 13F for the quarter before; a change under 0.1% of a holding counts as held
Funds reporting a position in NVCR in their 13F, each quarter; hover a bar for the shares they held
Filed so far for the quarter to 30 September 2026
2,671 funds have filed their 13F for the quarter so far; the rest are due by 16 November 2026. Of those, 33 reported a position in NovoCure Ltd.: 6 opened one, 12 added, 4 trimmed and 5 sold out, a net 159,212 shares bought.
The largest moves in the name among the funds that have filed, against each fund's previous 13F.
The well-known funds
Of the 44 funds followed here, 8 reported a position in NovoCure Ltd. in a 13F for the quarter ended 30 June 2026. The largest: FMR LLC, 17.4 million shares worth $263.2 million, 0.0% of its reported book. In the quarter, 5 funds added or opened a position and 3 trimmed or sold out; together they bought a net 546,983 shares, about $8.3 million at the funds' own value per share on 30 June 2026. A change under 0.1% of a holding counts as held.
| Fund | Shares | Value | Of its book | Change on the quarter | Status | Quarter ended | Filing |
|---|---|---|---|---|---|---|---|
| FMR LLC | 17,373,078 | $263.2 million | 0.0% | +303,929 | added | 30 June 2026 | 13F |
| Geode Capital Management | 2,798,351 | $42.4 million | 0.0% | +286,644 | added | 30 June 2026 | 13F |
| Renaissance Technologies | 1,951,911 | $29.6 million | 0.0% | +400,357 | added | 30 June 2026 | 13F |
| Baillie Gifford | 952,074 | $14.4 million | 0.0% | -119,510 | trimmed | 30 June 2026 | 13F |
| Point72 Asset Management | 803,120 | $12.2 million | 0.0% | -558,271 | trimmed | 30 June 2026 | 13F |
| Millennium Management | 278,068 | $4.2 million | 0.0% | +186,853 | added | 30 June 2026 | 13F |
| Citadel Advisors | 157,235 | $2.4 million | 0.0% | +71,099 | added | 30 June 2026 | 13F |
| Two Sigma Investments | 21,200 | $321,180 | 0.0% | -24,118 | trimmed | 30 June 2026 | 13F |
Value is what the fund reported.
Read more
Change is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.The largest holders
| Fund | Shares | Share of all | Value | Of its book | Change in shares | Filing |
|---|---|---|---|---|---|---|
| FMR LLC | 17,373,078 | 16.77% | $263.2 million | 0.01% | +303,929 | 13F |
| BlackRock, Inc. | 13,413,699 | 12.94% | $203.2 million | 0.00% | +219,934 | 13F |
| Soleus Capital Management, L.P. | 9,913,401 | 9.57% | $150.2 million | 5.17% | -578,990 | 13F |
| Vanguard Portfolio Management LLC | 6,272,490 | 6.05% | $95.0 million | 0.00% | +20,789 | 13F |
| Vanguard Capital Management LLC | 4,903,633 | 4.73% | $74.3 million | 0.00% | +221,569 | 13F |
| Morgan Stanley | 4,522,389 | 4.36% | $68.5 million | 0.00% | -19,137 | 13F |
| State Street Corp. | 2,866,546 | 2.77% | $43.4 million | 0.00% | +304,729 | 13F |
| Geode Capital Management, LLC | 2,798,351 | 2.70% | $42.4 million | 0.00% | +286,644 | 13F |
| Wells Fargo & Company | 2,528,093 | 2.44% | $38.3 million | 0.01% | -423,144 | 13F |
| Quantinno Capital Management LP | 2,223,455 | 2.15% | $33.7 million | 0.04% | -263,921 | 13F |
| Renaissance Technologies LLC | 1,951,911 | 1.88% | $29.6 million | 0.04% | +400,357 | 13F |
| JPMorgan Chase & Co. | 1,671,082 | 1.61% | $25.9 million | 0.00% | +740,916 | 13F |
| Healthcare of Ontario Pension Plan Trust Fund | 1,385,600 | 1.34% | $21.0 million | 0.03% | +659,200 | 13F |
| Palo Alto Investors LP | 1,280,439 | 1.24% | $19.4 million | 2.68% | no change | 13F |
| Nuveen, LLC | 1,232,087 | 1.19% | $18.7 million | 0.00% | +249,734 | 13F |
| Jacobs Levy Equity Management, Inc. | 1,164,072 | 1.12% | $17.6 million | 0.06% | -167,420 | 13F |
| Empowered Funds, LLC | 1,154,431 | 1.11% | $17.5 million | 0.09% | new | 13F |
| AQR Capital Management LLC | 1,102,131 | 1.06% | $16.7 million | 0.01% | +827,199 | 13F |
| Dimensional Fund Advisors LP | 1,091,946 | 1.05% | $16.5 million | 0.00% | +131,890 | 13F |
| D. E. Shaw & Co., Inc. | 1,022,480 | 0.99% | $15.5 million | 0.01% | +375,418 | 13F |
| Northern Trust Corp. | 973,202 | 0.94% | $14.7 million | 0.00% | +89,624 | 13F |
| C WorldWide Group Holding A/S | 971,784 | 0.94% | $14.7 million | 0.35% | no change | 13F |
| Goldman Sachs Group Inc. | 963,917 | 0.93% | $14.6 million | 0.00% | +218,482 | 13F |
| Baillie Gifford & Co. | 952,074 | 0.92% | $14.4 million | 0.01% | -119,510 | 13F |
| Silvercrest Asset Management Group LLC | 928,740 | 0.90% | $14.1 million | 0.09% | +143,935 | 13F |
| Charles Schwab Investment Management Inc. | 923,670 | 0.89% | $14.0 million | 0.00% | +86,176 | 13F |
| BNP Paribas Financial Markets | 922,009 | 0.89% | $14.0 million | 0.01% | +213,716 | 13F |
| Algert Global LLC | 856,322 | 0.83% | $13.0 million | 0.15% | +230,525 | 13F |
| Point72 Asset Management, L.P. | 803,120 | 0.78% | $12.2 million | 0.02% | -558,271 | 13F |
| Bank of America Corp. | 762,724 | 0.74% | $11.6 million | 0.00% | +592,711 | 13F |
| Vanguard Fiduciary Trust Co. | 752,531 | 0.73% | $11.4 million | 0.00% | +39,762 | 13F |
| Connor, Clark & Lunn Investment Management Ltd. | 661,280 | 0.64% | $10.0 million | 0.02% | -55,259 | 13F |
| Qube Research & Technologies Ltd | 605,874 | 0.58% | $9.2 million | 0.01% | +449,252 | 13F |
| Panagora Asset Management Inc. | 540,687 | 0.52% | $8.2 million | 0.03% | +463,565 | 13F |
| Balyasny Asset Management L.P. | 479,999 | 0.46% | $7.3 million | 0.01% | +468,168 | 13F |
| Essex Investment Management Co. LLC | 439,648 | 0.42% | $6.7 million | 0.87% | -12,722 | 13F |
| Franklin Resources Inc. | 434,360 | 0.42% | $6.6 million | 0.00% | +145,064 | 13F |
| Schroder Investment Management Group | 415,340 | 0.40% | $6.4 million | 0.01% | -604,629 | 13F |
| Citigroup Inc. | 415,517 | 0.40% | $6.3 million | 0.00% | +278,507 | 13F |
| HRT Financial LP | 392,319 | 0.38% | $5.9 million | 0.01% | new | 13F |
| Legal & General Group Plc | 325,809 | 0.31% | $4.9 million | 0.00% | -5,128 | 13F |
| Coppell Advisory Solutions LLC | 38,953 | 0.04% | $4.9 million | 0.40% | 13F | |
| Jump Financial, LLC | 311,349 | 0.30% | $4.7 million | 0.05% | -57,028 | 13F |
| Bank of New York Mellon Corp | 305,516 | 0.29% | $4.6 million | 0.00% | +24,045 | 13F |
| UBS Group AG | 292,638 | 0.28% | $4.4 million | 0.00% | +46,821 | 13F |
| Susquehanna Portfolio Strategies, LLC | 288,772 | 0.28% | $4.4 million | 0.07% | +149,072 | 13F |
| Millennium Management LLC | 278,068 | 0.27% | $4.2 million | 0.00% | +186,853 | 13F |
| Ieq Capital, LLC | 274,961 | 0.27% | $4.2 million | 0.02% | -39,773 | 13F |
| Tudor Investment Corp. Et Al | 269,027 | 0.26% | $4.1 million | 0.02% | +46,218 | 13F |
| BNP Paribas Asset Management Holding S.A. | 262,368 | 0.25% | $4.0 million | 0.00% | -247,274 | 13F |
The 50 largest of the 218 funds that reported a position in NVCR in their 13F for the quarter ended 30 June 2026, by the value each reported.
Read more
Share of all is the fund's part of all the shares the funds reported. Change is shares against the fund's 13F for the quarter before. A 13F lists a manager's long positions in US-listed shares at the quarter's end. What is a 13F?Options the funds reported on NVCR
| Fund | Option | Shares under the options | Value of those shares | Quarter ended | Filing |
|---|---|---|---|---|---|
| Citadel Advisors | Calls | 197,600 | $3.0 million | 30 June 2026 | 13F |
| Citadel Advisors | Puts | 18,900 | $286,335 | 30 June 2026 | 13F |
A 13F lists calls and puts by the shares they cover and what those shares were worth at the quarter's end, not what the options cost.
Read more
They are not counted in the holdings above. A put gains when the stock falls, a call when it rises, and a fund may hold either to hedge.Schedule 13D and 13G filed on the name, last twelve months
| Filed | Schedule | Who | Holding | Of the class | Event date | Rule or purpose | Filing |
|---|---|---|---|---|---|---|---|
| 8 May 2026 | 13G/A | Soleus Capital Master Fund, L.P. and 11 others | 10.5 million | 9.1% | 31 March 2026 | passive, under 20% (13d-1(c)) | EDGAR |
| 28 April 2026 | 13G | Vanguard Portfolio Management and 1 other | 6.3 million | 5.6% | 31 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 26 March 2026 | 13G/A | The Vanguard Group and 1 other | 0 | 0.0% | 13 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 12 February 2026 | 13G/A | Soleus Capital Master Fund, L.P. and 11 others | 8.5 million | 7.6% | 31 December 2025 | passive, under 20% (13d-1(c)) | EDGAR |
| 13 November 2025 | 13G/A | Capital World Investors and 1 other | 2.0 million | 1.8% | 30 September 2025 | passive, institutional (13d-1(b)) | EDGAR |
| 7 November 2025 | 13G/A | Soleus Capital Master Fund, L.P. and 11 others | 9.6 million | 8.6% | 30 September 2025 | passive, under 20% (13d-1(c)) | EDGAR |
A Schedule 13D is filed by anyone who crosses 5% of a class with intent to influence; a 13G by a passive holder.
Read more
Amendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short. 13D and 13GFails to deliver
| Settlement date | Shares failed | Price | File |
|---|---|---|---|
| 11 September 2026 | 12,072 | $15.35 | SEC |
| 31 August 2026 | 1,422 | $17.82 | SEC |
| 27 August 2026 | 22,282 | $17.89 | SEC |
| 24 August 2026 | 1,376 | $17.10 | SEC |
Shares that failed to deliver at settlement, per day, from the SEC's half-month files, which arrive about two weeks after the period.